Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
A single--blind, randomized, placebo--controlled phase II study to evaluate the impact of
oral bisphosphonate treatment on bone mineral density in osteopenic women receiving aromatase
inhibitors as adjuvant treatment.